Rice lands grant to improve time-release drugs
HOUSTON – (Sept. 21, 2021) – Time-released drugs are about to get a geometry lesson, thanks to bioengineers at Rice University.
Rice lands grant to improve time-release drugs
HOUSTON – (Sept. 21, 2021) – Time-released drugs are about to get a geometry lesson, thanks to bioengineers at Rice University.
NIH funds effort to customize treatment of movement impairments
Existing treatments for movement impairments are “off the rack” rather than “custom-tailored,” but B.J. Fregly, a Rice University professor of mechanical engineering and bioengineering, wants to change that situation.
Dashboard displays troubling trend of unexplained deaths
‘Slow-burning background crisis’ revealed in new work by Rice humanities researcher John Mulligan.
Rice lab dives deep for DNA’s secrets
Structural biologist Yang Gao receives a five-year National Institutes of Health grant to detail how complex protein chains replicate DNA and fix errors on the fly. What they find could help treat genomic disease, including cancer.
Rice, Baylor win defense grant to advance metastasis study
Rice University chemist Han Xiao and biologist Xiang Zhang at Baylor College of Medicine have won a $2.3 million Department of Defense grant to expand their efforts to halt bone cancer metastasis.
‘Smart cells’ show promise to treat disease
Laura Segatori wins NIH backing to develop synthetic biological circuits for cells that may someday sense trouble and respond by making just enough of the appropriate drugs.
When many act as one, data-driven models can reveal key behaviors
Data science approaches can reveal subtle clues about the origins of such collective behaviors as aggregation of bacteria.
Targeted tumors attack not-innocent bystanders
Antibody-drug conjugates developed are found to attack not only targeted tumor cells but also nontargeted “bystanders.”
Drug doubles down on bone cancer, metastasis
Researchers at Rice University and Baylor College of Medicine develop an antibody conjugate called BonTarg that delivers drugs to bone tumors and inhibits metastasis.
Scientists seek details of cancer’s evolutionary tree
Rice University computer scientists will take full advantage of new technology to sequence the genome of a single cell to decode mysteries contained in tumors.
Reversal speeds creation of important molecule
A Rice lab’s reverse approach to making halichondrin B is the shortest route to a “rather complex and important molecule."
Study examines how breast implant surfaces affect immune response
Rice University bioengineers collaborated on a six-year study that systematically analyzed how the surface architecture of silicone breast implants influences adverse side effects.
NIH grant boosts computational search for cancer drugs
Computer scientist Lydia Kavraki of Rice University’s Brown School of Engineering has won a prestigious National Institutes of Health U01 grant to develop a new approach to model and analyze protein-ligand interactions in cancer research.
NIH supports mathematical optimization of tumor treatment
A new strategy to reduce the side effects suffered by patients undergoing treatment for head and neck cancers now has the support of the National Institutes of Health.
Biologists construct a ‘periodic table’ for cell nuclei
A team of biologists studying the tree of life has unveiled a new classification system for cell nuclei, and discovered a method for transmuting one type of cell nucleus into another.